N/A
N=60
Children's Use of the Built Environment for Physical Activity
Obesity · Overweight
Bottom Line
View on ClinicalTrials.gov: NCT01939405 ↗Enrolled (actual)
60
Serious AEs
—
Results posted
Oct 2017
Primary outcome: Primary: Moderate to Vigorous Physical Activity (MVPA) — -1.9; 1.07 minutes
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- built environment use counseling (Behavioral)
- Age
- Pediatric · 10+ yrs
- Sex
- All
- Sponsor
- Massachusetts General Hospital
- Primary completion
- May 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Moderate to Vigorous Physical Activity (MVPA) |
-1.9; 1.07 | — |
| SECONDARY Moderate-to-Vigorous Physical Activity (MVPA) |
0.5; 6.3 | — |
| SECONDARY Sedentary Time |
-22.9; -4.4 | — |
| SECONDARY Sedentary Time |
-22.9; -4.4 | — |
Summary
The study aims are to develop and test the feasibility of a pediatric physical activity intervention that incorporates personal information on use of the built environment, and test the intervention's preliminary efficacy at increasing physical activity. The investigators hypothesize that it will be feasible to incorporate and measure changes in empiric GIS (geographic information system), GPS (global positioning system), and accelerometer feedback in the office setting as demonstrated by: i) Completeness of GPS and accelerometer data collection (primary measure of feasibility), ii) Participation rates among adolescents in the intervention group compared to the control group, and iii) Acceptability to patients as measured by adolescent satisfaction.
Eligibility Criteria
Inclusion Criteria
- Adolescents ages 10-16 years
- BMI > 85th percentile for age and sex
Exclusion Criteria
- Physical conditions impairing ambulation
- Adolescents who do not speak English
- Adolescents who have missed more than 2 scheduled doctor's appointments during the past 5 years
- Adolescents who are receiving any other form of physical activity counseling/intervention at the time of enrollment
Data sourced from ClinicalTrials.gov (NCT01939405). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.